Prot# CLAVELA (CP4055-306): A Randomised Phase III Study of Elacytarabine vs. Investigator's Choice in Patients with Late Stage Acute Myeloid Leukaemia

Project: Research project

Project Details

StatusFinished
Effective start/end date3/16/11 → 3/16/14

Funding

  • INC Research, LLC (CLAVELA (CP4055-306) // CLAVELA (CP4055-306))
  • Clavis Pharma ASA (CLAVELA (CP4055-306) // CLAVELA (CP4055-306))